Crosstalk of lipids and inflammation in atherosclerosis: the PRO of PGRN? (Q47776572)

5 February 2018

editorial

0 references

title

Crosstalk of lipids and inflammation in atherosclerosis: the PRO of PGRN? (English)

1 reference

5 February 2018

1 reference

2

Gerard Pasterkamp

1 reference

5 February 2018

Saskia C A de Jager

1

1 reference

5 February 2018

publication date

14 August 2013

1 reference

5 February 2018

published in

Cardiovascular Research

1 reference

5 February 2018

volume

100

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

4-6

1 reference

5 February 2018

Atherosclerosis — An Inflammatory Disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Insights into the role of progranulin in immunity, infection, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Arterial, venous and other vascular risk factors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Progranulin expression in advanced human atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

Secreted progranulin is a homodimer and is not a component of high density lipoproteins (HDL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT199

21 January 2018

Identifiers

DOI

10.1093/CVR/CVT199

1 reference

5 February 2018

PubMed ID

23946497

1 reference

5 February 2018